| |
Quantitation makes a major difference.
The fact is, NeuroQ™ goes beyond the ability of the eye to discern a very subtle grayscale. Colors make it easy to determine normal (blue) from abnormal (purple to red). The most recent study shows that quantitative analysis with NeuroQ™ increases diagnostic accuracy a remarkable 20%.
|
| |
Referring physicians really like it.
A definitive, quantitative differential diagnosis delivered with NeuroQ™ color-coded jpegs attached to your PET report is very important to the physician treating dementia. States Avery Brinkley, M.D., "It has a real impact on whether they refer, I can tell you that."
|
| |
A major impact on therapy.
Since treatment is specific to each type of dementia, it is critical that the diagnosis is accurate. Case in point: fronto-temporal and Alzheimer's. Each is treated quite differently with medications. Some Alzheimer's patients treated for fronto-temporal get worse, and vice versa.
|
| |
Track the progression of dementia.
NeuroQ™ can analyze the difference between two PET brain studies of the same patient providing an analysis for progression or regression of disease. Other programs can only analyze in comparison to a database of normal brain scans.
|
| |
Epilepsy analysis tool for pre-surgical TLE.
EQuAL™ is an epilepsy analysis tool integrated into NeuroQ™. For the first time, Brain PET imaging can be effectively used to determine, in advance of surgery, the likelihood a TLE patient will have a post-surgery seizure.
|
| |